Press Releases

A “Call for Standards” A Clinical Collaboration Involving Industry Experts

AVENTURA, FLORIDA (May 30, 2018) – Specialty Med Training and PRP Science, leading companies who are working to advance the field of regenerative medicine, are sponsoring a live, interactive lecture on Wednesday, June 13, 2018 from 6-pm to 8-pm at Serendipity Labs,20807 Biscayne Blvd #100, Aventura, FL 33180. The featured “Call for Clinical Collaboration” will include a multispecialty panel of expert scientists and physicians recognized as “thought leaders” in Platelet Rich Plasma (PRP). Read More

“Medical Mastermind Workshop”: A One-of-a-Kind, Hands-On PRP and Shockwave Therapy Training Opportunity

Specialty Med Training, one of the nation’s largest training, research and marketing companies, who helps physicians bring the latest regenerative therapies and treatment options to their patients, is hosting a one-of-a-kind, 2-day hands-on training on Friday and Saturday, October 5-6, 2018 in White Plains, NY. WHITE PLAINS, N.Y. (PRWEB) August 08, 2018 — Specialty Med Training, one of the nation’s largest training, research and Read More

Articles

Plateletrich Plasma Injections for Facial Rejuvenation

Peter A. Everts, Pedro Contreiras Pinto and Leonor Girão discuss how the use of PurePRP® injections can lead to fewer wrinkles and firmer skin with an improved sub-epidermal low echogenic band density.

Since platelet-rich plasma (PRP) contains several growth factors, cell adhesion molecules, and various cytokines, it was hypothesized that it could play a role in facial rejuvenation with emphasis on fibroblast activation and type I collagen expression in human fibroblasts. However, there are significant differences between PRP systems with regard to so-called plasma-based PRP and buffy coat PRP. The aim of this study was to assess the clinical effectiveness of three buffy coat Pure PRP injections in volunteers for facial rejuvenation, using specific and objective biometric devices for skin improvement analysis.  Read More

Shock waves may change future of ED therapy

Procedure offers promise of disease modification vs. symptomatic treatment.

t’s hard to argue against an erectile dysfunction treatment that is poten- tially disease modifying, is nonin- vasive, and seems to do no harm. The treatment, low-intensity shock wave therapy, has yet to earn the FDA’s approval but is widely used in other countries. Early results from ongoing U.S. trials are promising. Read More